Vedolizumab-5028: A Retrospective UK Chart Review of Early Vedolizumab (Entyvio®) Experience: Real World Treatment, Effectiveness and Safety in Inflammatory Bowel Disease (IBD)

11/03/2016
21/11/2024
EU PAS number:
EUPAS12537
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information
Publications